| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 49.378 | 48.910 | 47.849 | 62.850 | 63.039 | 153.626 | 169.674 | 193.028 | 223.261 | 235.239 |
| Total Income - EUR | 49.485 | 48.918 | 47.849 | 62.850 | 63.045 | 153.626 | 169.674 | 193.028 | 223.261 | 235.239 |
| Total Expenses - EUR | 55.920 | 45.489 | 49.797 | 58.096 | 61.141 | 132.039 | 139.461 | 170.209 | 192.835 | 200.176 |
| Gross Profit/Loss - EUR | -6.435 | 3.429 | -1.948 | 4.754 | 1.905 | 21.588 | 30.213 | 22.819 | 30.426 | 35.063 |
| Net Profit/Loss - EUR | -7.919 | 2.451 | -2.427 | 4.118 | 1.269 | 20.269 | 28.409 | 20.959 | 28.113 | 27.903 |
| Employees | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 1 |
Check the financial reports for the company - Yil Vice Bioterra Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 33.280 | 54.093 | 56.311 | 56.703 | 61.755 | 49.416 | 46.613 | 44.069 | 48.026 | 47.426 |
| Inventories | 32.435 | 53.607 | 55.726 | 52.407 | 61.248 | 42.562 | 41.384 | 35.738 | 39.866 | 30.145 |
| Receivables | 60 | 63 | 63 | 54 | 0 | 3.216 | 0 | 122 | 134 | 31 |
| Cash | 785 | 423 | 523 | 4.242 | 506 | 3.637 | 5.230 | 8.208 | 8.026 | 17.251 |
| Shareholders Funds | -10.566 | -8.007 | -10.299 | -5.992 | -4.607 | 15.749 | 38.314 | 21.162 | 28.315 | 5.818 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 43.846 | 62.100 | 66.610 | 62.695 | 66.362 | 33.666 | 8.299 | 27.249 | 19.723 | 41.608 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4776 - 4776" | |||||||||
| CAEN Financial Year |
4631
|
|||||||||
Comments - Yil Vice Bioterra Srl